Cygnus Research
Executive Summary
Privately-held Redwood City, California-based firm announces a Japanese 50/50 joint venture with Nichiban Co., Ltd. to develop and manufacture transdermal drug delivery systems for pharmaceutical firms in that country. Nichiban markets bandages and surgical tapes and has developed an adrenocortical steroid tape (Tokuderm) and a nitroglycerin transdermal patch (Herzer or Millisrol Tape). The new venture Nichiban DDS K.K. will be headquartered in Osaka.